BLCO: Multiplikator P/S Bausch Health

Simbol lan logo merek Bausch & Lomb (BLCO)

Bausch + Lomb Corporation (BLCO) management is restoring autonomy following the spin-off by modernizing its ophthalmology equipment. The GURU.Markets website features this chart of the trading value-to-revenue ratio, where 1.40 serves as the final level marker. Global reach and a diversified portfolio protect the business from dumping. Stable demand for vision correction is supported by a robust manufacturing base in Europe and the US.

Rasio rega marang pendapatan: Bausch + Lomb (BLCO) kanggo 28.04.2023 - 17.11.2026

Rincian analitis perusahaan Bausch + Lomb Corporation (BLCO)

- rega saiki lan proyeksi nilai saham:
Ringkesan analitik perusahaan:Bausch + Lomb Corp, BLCO
Produk asli Bausch Health

Selecting reliable assets requires analyzing the ratio of market capitalization to annual turnover, which determines the degree of business overvaluation relative to its operational efficiency. In GURU.Markets, the price-to-sales ratio for Bausch + Lomb Corporation (BLCO) confirms valuation stability, as the humanitarian status of ophthalmological products minimizes geopolitical risks, ensuring predictable revenue dynamics on the chart.